Back to search

Article

Pretreatment heterogeneous enhancement pattern of hepatocellular carcinoma can be new predictor for early response to lenvatinib

2019-07-03

Abstract excerpt

<title>Abstract</title> <p>Background: The aims of this study were to identify useful predictors of early tumor response to lenvatinib, and to evaluate the utility of estimation of tumor differentiation from pretreatment image analysis. <h4>Methods:</h4> We evaluated 37 consecutive patients with unresectable hepatocellular carcinoma (HCC) diagnosed by dynamic computed tomography (CT) who received lenvatinib. Pret...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f8778140-ce6c-57c7-b744-f6ea3fa4fb1f
DOI
10.21203/rs.2.10911/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pretreatment heterogeneous enhancement pattern of hepatocellular carcinoma can be new predictor for early response to lenvatinibDOI 10.21203/rs.2.10911/v1
Select a neighboring publication to make it the new centre.